Literature DB >> 26424916

Identification of immunodominant proteins from Mannheimia haemolytica and Histophilus somni by an immunoproteomic approach.

Angel H Alvarez1, Abel Gutiérrez-Ortega1, Rodolfo Hernández-Gutiérrez1.   

Abstract

Mannheimia haemolytica and Histophilus somni are frequently isolated from diseased cattle with bovine respiratory disease (BRD). They compromise animal lung function and the immune responses generated are not sufficient to limit infection. Identification of specific immunogenic antigens for vaccine development represents a great challenge. Immunogenic proteins were identified by immunoproteomic approach with sera from cattle immunized with a commercial cellular vaccine of M. haemolytica and H. somni. Proteins of M. haemolytica were identified as solute ABC transporter, iron-binding protein, and hypothetical protein of capsular biosynthesis. Histophilus somni proteins correspond to porin, amino acid ABC transporter, hypothetical outer membrane protein, cysteine synthase, and outer membrane protein P6. Although these antigens share strong similarities with other proteins from animal pathogens, the ABC system proteins have been associated with virulence and these proteins could be considered as potential vaccine candidates for BRD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26424916      PMCID: PMC4581680     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  19 in total

1.  Immunological characterization of the major outer membrane protein of Haemophilus somnus.

Authors:  Y Tagawa; F Bastida-Corcuera; L B Corbeil
Journal:  Vet Microbiol       Date:  2000-02       Impact factor: 3.293

2.  Molecular cloning of the Pasteurella haemolytica pomA gene and identification of bovine antibodies against PomA surface domains.

Authors:  H Zeng; K Pandher; G L Murphy
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Vaccine containing iron-regulated proteins of Pasteurella haemolytica A2 enhances protection against experimental pasteurellosis in lambs.

Authors:  N J Gilmour; W Donachie; A D Sutherland; J S Gilmour; G E Jones; M Quirie
Journal:  Vaccine       Date:  1991-02       Impact factor: 3.641

4.  Identification of immunogenic, surface-exposed outer membrane proteins of Pasteurella haemolytica serotype 1.

Authors:  K Pandher; G L Murphy; A W Confer
Journal:  Vet Microbiol       Date:  1999-03-12       Impact factor: 3.293

5.  Serum IgG response in calves to the putative pneumonic virulence factor Gs60 of Mannheimia haemolytica A1.

Authors:  Shahriar Orouji; Douglas C Hodgins; Reggie Y C Lo; Patricia E Shewen
Journal:  Can J Vet Res       Date:  2012-10       Impact factor: 1.310

6.  Duration of serum antibody responses following vaccination and revaccination of cattle with non-living commercial Pasteurella haemolytica vaccines.

Authors:  A W Confer; R W Fulton; K D Clinkenbeard; B A Driskel
Journal:  Vaccine       Date:  1998-12       Impact factor: 3.641

7.  An electrophoretic characterization of iron-transporting proteins in Mannheimia haemolytica A1.

Authors:  A Puchalski; R Urban-Chmiel; M Dec; A Wernicki
Journal:  Pol J Vet Sci       Date:  2013       Impact factor: 0.821

8.  Clinical and serological evaluation of a Pasteurella haemolytica A1 capsular polysaccharide vaccine.

Authors:  J A Conlon; P E Shewen
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

9.  Expression of a modified Mannheimia haemolytica GS60 outer membrane lipoprotein in transgenic alfalfa for the development of an edible vaccine against bovine pneumonic pasteurellosis.

Authors:  Raymond W H Lee; Mette Cornelisse; Asma Ziauddin; Penelope J Slack; Douglas C Hodgins; Judith N Strommer; Patricia E Shewen; Reggie Y C Lo
Journal:  J Biotechnol       Date:  2008-03-22       Impact factor: 3.307

10.  Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE-LKT (SAC89) protein.

Authors:  A W Confer; S Ayalew; M Montelongo; D L Step; J H Wray; R D Hansen; R J Panciera
Journal:  Vaccine       Date:  2008-10-01       Impact factor: 3.641

View more
  1 in total

1.  Identification of Leukotoxin and other vaccine candidate proteins in a Mannheimia haemolytica commercial antigen.

Authors:  Paula Tucci; Verónica Estevez; Lorena Becco; Florencia Cabrera-Cabrera; Germán Grotiuz; Eduardo Reolon; Mónica Marín
Journal:  Heliyon       Date:  2016-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.